🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Charles River Laboratories International, Inc.

CRL Healthcare
$290.19 +$3.36 (1.17%)
Market Cap: $13.85 B
Gurus Holding
8
Popularity Rank
#919
% of Shares Held
4.22%
Net Activity (Q2 2026)
+$16.57 M

Guru Ownership Trend

Guru Analysis for Charles River Laboratories International, Inc. (CRL)

Charles River Laboratories International, Inc. (CRL), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 8 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $584.43 M.

Top institutional holders include John Rogers and Joel Greenblatt.

Institutional sentiment is currently Bullish. This is evidenced by a $16.57 M net inflow during the quarter.

Recent activity highlights Jefferies Group who opened a new position. Conversely, Louis Moore Bacon reduced exposure by 91.0%.

Key Holders

Top 5 by Value

$341.59 M
$98.23 M
$9.97 M
$4.14 M
$1.61 M

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$35.36 M
Total Buy Value
New Buys 3
Additions 2
-$18.79 M
Total Sell Value
Reductions 3
Sold Out 2

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
5
Net Buyers
5

FAQs for Charles River Laboratories International, Inc. (CRL)

Major holders include John Rogers ($341.59 M), Joel Greenblatt ($98.23 M), Cliff Asness ($9.97 M). According to the latest reported data, 8 tracked investment managers collectively hold approximately 2.01 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $16.57 M, with 5 managers increasing positions and 5 managers reducing holdings.

During the most recent reporting period, 3 managers trimmed their positions, while 2 fully exited CRL. The total reported sell value was $18.79 M.

Yes, 3 managers opened new positions in CRL, and 2 increased their existing holdings. The total reported buy value was $35.36 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
3.41% Add 4.3% 1,506,185 $341.59 M Q2 2026
0.23% Add 20.8% 433,146 $98.23 M Q2 2026
0.00% Reduce -38.1% 44,344 $9.97 M Q2 2026
0.03% New Buy 18,270 $4.14 M Q2 2026
0.02% Reduce -41.7% 7,103 $1.61 M Q2 2026
0.01% Reduce -91.0% 3,892 $882,667 Q2 2026
0.00% New Buy 1,002 $227,394 Q2 2026
0.00% New Buy 14 $3,158 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form